IHS Chemical Week

EnviroTech :: R&D

Novartis to Invest $1 Billion on R&D Center in China; Opens $250-Million API Site at Changshu

4:51 AM MST | November 3, 2009 | Deepti Ramesh

Novartis says it will invest $1 billion over the next five years, to increase pharmaceutical research and development (R&D) activities in China. The investment will involve a significant expansion of the Novartis Institute of BioMedical Research (CNIBR) at Shanghai, the company says. Novartis says it has also invested $250 million in a new technical center at Changshu, China, which opened this week, and the center is focused on technical research, development and manufacturing of active pharmaceutical ingredients (APIs). The facility is expected to be a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa